Related Experiment Videos
Glucose concentration at possible sensor tissue implant sites
Diabetes Care
|May 1, 1982
Summary
Researchers explored alternative locations for implantable glucose sensors outside the bloodstream. Extravascular spaces, such as subcutaneous tissue, show potential for continuous glucose monitoring in closed-loop insulin systems.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Medical Devices
Background:
- Closed-loop insulin systems require accurate glucose monitoring.
- Implantable glucose sensors are crucial for automated insulin delivery.
- The bloodstream presents a hostile environment for implantable sensors.
Purpose of the Study:
- To investigate the feasibility of placing glucose sensors in extravascular spaces.
- To evaluate alternative locations for continuous glucose monitoring.
- To identify potential sites for improved sensor performance in automated insulin systems.
Main Methods:
- Assessed glucose concentrations in various extravascular fluid spaces.
- Included subcutaneous extracellular space, peritoneum, pleura, and pericardium.
- Monitored glucose levels under steady-state conditions.
Main Results:
- Glucose concentrations in extravascular spaces generally ranged from 50 to 115 mg/dL.
- Observed instances of lower glucose values, indicating variability.
- Experimental design limitations prevented monitoring of rapid dynamic changes.
Conclusions:
- Extravascular spaces are compatible with glucose sensor placement.
- The extracellular, extravascular environment may be a suitable locus for glucose sensors.
- Further research is needed to validate sensor performance in these alternative sites.